ALBANY, N.Y. (AP) — New York Attorney General Eric Schneiderman is pressing TransUnion and Experian to explain what cybersecurity they have in place to protect sensitive consumer information following a recent breach at Equifax that exposed the data of 143 million Americans.In letters to executives at the two credit monitoring companies, the Democratic attorney general asked them to describe their existing security systems as well as what changes they've made since the Equifax cyberattack."The unprecedented data breach experienced by Equifax Inc.
NYS Entity Status
NYS Filing Date
JULY 16, 2014
NYS DOS ID#
NYS Entity Type
DOMESTIC NOT-FOR-PROFIT CORPORATION
2014 - BANGLADESH MEDICAL ASSOCIATION OF NORTH AMERICA, NEW YORK (NY) CHAPTER, INC.
Around the Web
- NY AG presses TransUnion, Experian for cybersecurity details
By DAVID KLEPPER, Associated Press - Tuesday Sep 19, 2017
- The Look: New York City Parks in the Summer: Romance, Games and a Performance for a Dying Tree
By DANIEL ARNOLD, JOANNA NIKAS and EVE LYONS - Saturday Sep 2, 2017
Daniel Arnold spent the last two months photographing parks in all five boroughs. The experience showed him “a very different pulse of the city.”
- North Korea Accuses U.S. of ‘Mugging’ Its Diplomats in New York
By CHOE SANG-HUN - Sunday Jun 18, 2017
Officials returning from a United Nations conference were about to board a plane when federal agents seized a package they were carrying.
- Man Killed in 9/11 Attacks Is Identified by DNA Testing
By ASHLEY SOUTHALL - Monday Aug 7, 2017
The man, whose name was withheld by officials at his family’s request, was the first Sept. 11 victim to be identified in more than two years.
- Food & Wine Magazine Will Leave New York for Alabama
By STEPHANIE STROM - Friday Jun 23, 2017
The move reflects a changing business in which traditional food magazines, and a Manhattan address, are less important.
- Traces of Crime: How New York’s DNA Techniques Became Tainted
By LAUREN KIRCHNER - Monday Sep 4, 2017
The city’s medical examiner has been a pioneer in analyzing complex DNA samples. But two methods were recently discontinued, raising questions about thousands of cases.